A Self-assembling and Self-adjuvanting Nanoparticular Therapeutic Vaccine Against Cervical Cancer

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

One in every three Australians will be diagnosed with cancer in their lifetime according to the Australia Cancer Foundation. The proposed project aims to develop pathogen-like bullets based on self-organized nanoparticles which would become a strong weapon against cervical cancer.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $387,858.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nanomedicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adjuvant | cancer immunotherapy | cancer vaccine | cervical cancer | drug delivery systems | nanotechnology | peptide synthesis | vaccine strategy